Listen "Episode 64: Emily Sims, MD, Pediatric Endocrinologist and Assistant Professor of Pediatrics at Indiana University"
Episode Synopsis
In this episode, Dr. Emily Sims joins us to discuss her research focused on diabetes risk factors and treatments to predict or slow diabetes progression. Tune in to learn more about her recent publication on teplizumab, titled "Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals".
Click here to read the full paper.
Click here to read the full paper.
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.